Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Biopharm Drug Dispos. 2018 Apr;39(4):218–231. doi: 10.1002/bdd.2128

Figure 4.

Figure 4

3D mesh plot illustrating the effects of renal function (100%–10%) on (A) renal clearance (CLR) and (B) overall clearance (CL) of GHB (1500 mg/kg single IV bolus dose), when expression of DTs is altered (VMAX, BBM and VMAX, BLM parameters were perturbed ± 2 and 5-fold)